MADRID (Reuters) -Grifols’s net profit almost tripled from a year earlier, which the Spanish drugmaker said reinforced its confidence in meeting its full-year guidance.
Reported group profit grew by 179% in the first three months of the year to 60 million euros ($66.41 million) while adjusted earnings before interest, taxes, depreciation and amortisation (EBITDA) grew 14.2% to 400 million euros, Grifols said in a statement on Monday.
Net revenue rose 7.4% 1.79 billion euros in the first quarter thanks to a strong performance from its plasma-derived medicine business.
($1 = 0.9035 euros)
(Reporting by Charlie Devereux; editing by Inti Landauro)
Brought to you by www.srnnews.com
